A Consultant Medical Oncologist at Monash Health, Associate Professor Azad’s clinical and research work is focused on urological malignancies, especially prostate cancer.
Associate Professor Azad completed his medical oncology training and a PhD in Melbourne before embarking on a fellowship at the University of British Columbia in Vancouver, where he led cutting-edge work investigating mechanisms of therapeutic resistance and response in advanced prostate cancer patients through genomic analysis of circulating cell-free DNA (cfDNA) at the British Columbia Cancer Agency.
Since taking up his position at the Monash Health Translation Precinct (MHTP) in 2015, Associate Professor has been actively involved in clinical trials with novel drug treatments and translational biomarker studies.
Associate Professor Azad’s clinical and research activities have resulted in a strong academic record with numerous high-impact publications and over $4.5M in competitive funding.
Since returning from Canada, he has also taken a key leadership role in the Australian uro-oncology community as Chair, Translational Research Committee of the ANZUP Clinical Trials Group.
Associate Professor Azad said he is very pleased to receive this promotion, which is a nice recognition for his clinical and academic endeavours over recent years.
“I am especially grateful to my family especially my wife and parents, and my mentors both in Canada and Australia,” he said.